Business Context and Reporting Period
Company: The Procter & Gamble Company (P&G)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended September 30, 2008
Business Overview: P&G is a global consumer products company operating in three Global Business Units (GBUs): Beauty, Health & Well-Being, and Household Care. Products are sold in over 180 countries.
Key Financial Metrics
| Metric (in millions, except per share) | Q1 2009 (Sep 30, 2008) | Q1 2008 (Sep 30, 2007) |
|---|---|---|
| Net Sales | $22,026 | $20,199 |
| Net Earnings | $3,348 | $3,079 |
| Diluted EPS | $1.03 | $0.92 |
| Operating Cash Flow | $3,251 | $3,230 |
| Free Cash Flow | $2,552 | $2,690 |
| Operating Margin | 21.3% | 21.9% |
| Effective Tax Rate | 28.5% | 27.6% |
| Total Debt (Short + Long Term) | $39,447 | $36,665 (Jun 30, 2008) |
| Cash and Cash Equivalents | $4,502 | $3,313 (Jun 30, 2008) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9% to $22.0 billion. Organic sales (excluding acquisitions, divestitures, and FX) grew 5%. Growth was driven by a 2% increase in unit volume, a 3% price increase, and a 5% favorable foreign exchange impact.
- Profitability: Net earnings rose 9% to $3.3 billion. Diluted EPS increased 12% to $1.03, outpacing earnings growth due to share repurchases.
- Margins: Gross margin decreased 240 basis points to 50.5% of net sales, primarily due to commodity-driven cost increases (approx. 400 bps impact) partially offset by price increases and cost savings. Operating margin declined 60 basis points to 21.3%.
- Segment Performance:
- Beauty: Sales up 12%; Earnings up 9%.
- Household Care: Sales up 10%; Earnings declined 9% in Fabric Care/Home Care due to high commodity costs, though Baby Care/Family Care earnings rose 20%.
- Health & Well-Being: Sales up 4%; Earnings up 2%.
- Balance Sheet: Short-term debt increased significantly to $21.1 billion (from $13.1 billion at June 30, 2008) to fund share repurchases. Total shareholders' equity decreased to $64.6 billion due to treasury stock purchases and currency translation adjustments.
Outlook, Risks, and Management Commentary
- Share Repurchases: The company repurchased $3.9 billion of treasury shares during the quarter under a program authorized in 2007. Approximately $16.1 billion remained available under the program as of September 30, 2008.
- Cost Pressures: Management highlighted ongoing volatility in commodity prices, raw materials, and foreign exchange. Pricing actions and cost savings projects are being utilized to mitigate these impacts.
- Legal and Regulatory Risks: P&G is subject to multiple investigations into potential competition law violations in the European Union (EU) and other countries. The company has identified some violations and is cooperating with authorities. While no formal claims have been made, management stated that fines could materially impact future income statements and cash flows, though amounts cannot currently be reasonably estimated.
- Market Risks: The filing notes risks associated with the global credit crisis, which could impact consumer demand, supplier relationships, and the company's ability to access credit markets for discretionary spending.
- Divestitures: Gains on the sale of businesses (ThermaCare, Dantrium, Dryel, and Western European Tissue business) contributed to non-operating income.
Investor Verification Checklist
- Commodity Cost Exposure: Verify the sustainability of gross margin recovery given the 400 basis point headwind from commodity costs in the quarter.
- EU Antitrust Fines: Monitor updates on European Union competition law investigations to assess potential magnitude of future fines and reserves.
- Liquidity and Debt: Review the company's ability to refinance short-term debt ($21.1 billion) in the context of the ongoing global credit crisis.
- Organic Growth Quality: Assess whether the 5% organic sales growth is driven by volume or price, and the potential impact of price increases on future volume trends.
- Share Buyback Impact: Evaluate the remaining $16.1 billion authorization and the company's commitment to capital allocation amidst economic uncertainty.